Published in Genet Med on August 27, 2015
Deep Phosphoproteomic Measurements Pinpointing Drug Induced Protective Mechanisms in Neuronal Cells. Front Physiol (2016) 0.83
Emerging Roles for the Immune System in Traumatic Brain Injury. Front Immunol (2016) 0.80
Actin dynamics and cofilin-actin rods in alzheimer disease. Cytoskeleton (Hoboken) (2016) 0.80
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease. Genome Med (2016) 0.78
New Drugs from Marine Organisms in Alzheimer's Disease. Mar Drugs (2015) 0.78
miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's disease. Alzheimers Res Ther (2016) 0.78
Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis. Mol Neurobiol (2017) 0.78
Therapies for Prevention and Treatment of Alzheimer's Disease. Biomed Res Int (2016) 0.77
Molecular and cellular aspects of age-related cognitive decline and Alzheimer's disease. Behav Brain Res (2016) 0.76
Lipid and Alzheimer's disease genes associated with healthy aging and longevity in healthy oldest-old. Oncotarget (2017) 0.75
Alzheimer's disease: presence and role of microRNAs. Biomol Concepts (2016) 0.75
Do Microglia Default on Network Maintenance in Alzheimer's Disease? J Alzheimers Dis (2016) 0.75
A Novel Single Nucleotide T980C Polymorphism in the Human Carboxypeptidase E Gene Results in Loss of Neuroprotective Function. PLoS One (2017) 0.75
Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data. Transl Psychiatry (2017) 0.75
Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort. Alzheimers Dement (Amst) (2016) 0.75
Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain. J Alzheimers Dis (2016) 0.75
Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genes. BMC Genomics (2016) 0.75
Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid. Front Neurol (2017) 0.75
Precocious Alterations of Brain Oscillatory Activity in Alzheimer's Disease: A Window of Opportunity for Early Diagnosis and Treatment. Front Cell Neurosci (2015) 0.75
Association study between the DNMT3A -448A>G polymorphism and risk of Alzheimer's disease in Caucasians of Italian origin. Am J Neurodegener Dis (2016) 0.75
The Rare-Variant Generalized Disequilibrium Test for Association Analysis of Nuclear and Extended Pedigrees with Application to Alzheimer Disease WGS Data. Am J Hum Genet (2017) 0.75
A Bayesian Model for the Prediction and Early Diagnosis of Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Copy Number Variants in Alzheimer's Disease. J Alzheimers Dis (2016) 0.75
Alzheimer's disease: Lost memories found. Nature (2016) 0.75
Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults. Am J Geriatr Psychiatry (2016) 0.75
Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders. Brain Res Bull (2016) 0.75
Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity. J Alzheimers Dis (2016) 0.75
Effect of the herbal formulation Shen-Zhi-Ling on an APP/PS1 mouse model of Alzheimer's disease by modulating the biliverdin reductase/heme oxygenase 1 system. Exp Ther Med (2017) 0.75
Characterization of pathogenic SORL1 genetic variants for association with Alzheimer's disease: a clinical interpretation strategy. Eur J Hum Genet (2017) 0.75
Alzheimer Disease: Scientific Breakthroughs and Translational Challenges. Mayo Clin Proc (2017) 0.75
Finding the right balance between precision medicine and personalized care. CMAJ (2017) 0.75
Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. Sci Rep (2017) 0.75
Interplay between protein glycosylation pathways in Alzheimer's disease. Sci Adv (2017) 0.75
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (1991) 16.77
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80
TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35
Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science (1995) 8.31
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature (2012) 8.10
The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement (2013) 7.69
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet (2005) 7.66
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet (1994) 7.07
Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry (2006) 6.68
Propagation of tau pathology in a model of early Alzheimer's disease. Neuron (2012) 6.23
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 5.94
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron (2004) 5.52
The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science (1987) 3.59
Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron (2013) 3.43
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest (2008) 3.36
Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet (2013) 3.30
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature (2013) 2.79
Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann Neurol (2003) 2.72
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J (2009) 2.66
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science (2009) 2.30
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain (2006) 2.23
Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat (2012) 2.17
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry (2012) 1.84
Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet (1992) 1.76
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med (2014) 1.75
Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study. Lancet Neurol (2015) 1.67
Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet (1992) 1.62
Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell (2015) 1.61
Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry (2011) 1.59
Presenilin mutations in Alzheimer's disease. Hum Mutat (1998) 1.51
Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains. PLoS One (2012) 1.48
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology (2014) 1.47
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease. Nat Genet (2015) 1.46
Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain (2010) 1.45
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med (2014) 1.45
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med (2011) 1.44
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol (2007) 1.42
The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron (2014) 1.35
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet (1996) 1.26
CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci (2013) 1.21
Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe. Hum Mutat (2003) 1.20
No expectation to share incidental findings in genomic research. Lancet (2014) 1.20
Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism. Neurobiol Aging (2012) 1.19
PLD3 and sporadic Alzheimer's disease risk. Nature (2015) 1.15
Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions. Biol Psychiatry (2013) 1.10
Coding mutations in SORL1 and Alzheimer disease. Ann Neurol (2015) 1.09
Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener (2012) 1.08
Propagation of tau pathology in Alzheimer's disease: identification of novel therapeutic targets. Alzheimers Res Ther (2013) 1.00
Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease. Alzheimers Dement (2008) 1.00
C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2013) 1.00
Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues. Prog Neurobiol (2013) 0.98
ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status. Neurosci Lett (2013) 0.95
Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease. J Neural Transm (Vienna) (2012) 0.95
Alzheimer's risk variants in the clusterin gene are associated with alternative splicing. Transl Psychiatry (2011) 0.94
A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42. Alzheimers Dement (2015) 0.92
Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families. Am J Med Genet B Neuropsychiatr Genet (2010) 0.90
New applications of disease genetics and pharmacogenetics to drug development. Curr Opin Pharmacol (2014) 0.89
Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clin (2013) 0.89
Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach. J Alzheimers Dis (2015) 0.86
Diagnosis and management of Alzheimer's disease: past, present and future ethical issues. Prog Neurobiol (2013) 0.83
Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia. Am J Cardiol (1995) 0.77
Diffusion Kurtosis Imaging: A Possible MRI Biomarker for AD Diagnosis? J Alzheimers Dis (2015) 0.75
Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations. J Alzheimers Dis (2016) 0.75